17-1769982-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002615.7(SERPINF1):​c.215C>T​(p.Thr72Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.634 in 1,613,816 control chromosomes in the GnomAD database, including 329,446 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.68 ( 36046 hom., cov: 32)
Exomes 𝑓: 0.63 ( 293400 hom. )

Consequence

SERPINF1
NM_002615.7 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.725

Publications

112 publications found
Variant links:
Genes affected
SERPINF1 (HGNC:8824): (serpin family F member 1) This gene encodes a member of the serpin family that does not display the serine protease inhibitory activity shown by many of the other serpin proteins. The encoded protein is secreted and strongly inhibits angiogenesis. In addition, this protein is a neurotrophic factor involved in neuronal differentiation in retinoblastoma cells. Mutations in this gene were found in individuals with osteogenesis imperfecta, type VI. [provided by RefSeq, Aug 2016]
SERPINF1 Gene-Disease associations (from GenCC):
  • osteogenesis imperfecta type 6
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • osteogenesis imperfecta type 3
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • osteogenesis imperfecta type 4
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.7483504E-6).
BP6
Variant 17-1769982-C-T is Benign according to our data. Variant chr17-1769982-C-T is described in ClinVar as Benign. ClinVar VariationId is 322000.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.827 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SERPINF1NM_002615.7 linkc.215C>T p.Thr72Met missense_variant Exon 3 of 8 ENST00000254722.9 NP_002606.3
SERPINF1NM_001329904.2 linkc.-347C>T 5_prime_UTR_premature_start_codon_gain_variant Exon 2 of 7 NP_001316833.1
SERPINF1NM_001329903.2 linkc.215C>T p.Thr72Met missense_variant Exon 3 of 8 NP_001316832.1
SERPINF1NM_001329904.2 linkc.-347C>T 5_prime_UTR_variant Exon 2 of 7 NP_001316833.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SERPINF1ENST00000254722.9 linkc.215C>T p.Thr72Met missense_variant Exon 3 of 8 1 NM_002615.7 ENSP00000254722.4

Frequencies

GnomAD3 genomes
AF:
0.679
AC:
103173
AN:
151970
Hom.:
35998
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.835
Gnomad AMI
AF:
0.709
Gnomad AMR
AF:
0.607
Gnomad ASJ
AF:
0.721
Gnomad EAS
AF:
0.523
Gnomad SAS
AF:
0.480
Gnomad FIN
AF:
0.550
Gnomad MID
AF:
0.693
Gnomad NFE
AF:
0.643
Gnomad OTH
AF:
0.702
GnomAD2 exomes
AF:
0.609
AC:
153242
AN:
251434
AF XY:
0.606
show subpopulations
Gnomad AFR exome
AF:
0.837
Gnomad AMR exome
AF:
0.517
Gnomad ASJ exome
AF:
0.723
Gnomad EAS exome
AF:
0.543
Gnomad FIN exome
AF:
0.548
Gnomad NFE exome
AF:
0.649
Gnomad OTH exome
AF:
0.631
GnomAD4 exome
AF:
0.630
AC:
920378
AN:
1461726
Hom.:
293400
Cov.:
74
AF XY:
0.625
AC XY:
454704
AN XY:
727170
show subpopulations
African (AFR)
AF:
0.848
AC:
28385
AN:
33480
American (AMR)
AF:
0.527
AC:
23582
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.725
AC:
18949
AN:
26136
East Asian (EAS)
AF:
0.495
AC:
19665
AN:
39698
South Asian (SAS)
AF:
0.492
AC:
42459
AN:
86258
European-Finnish (FIN)
AF:
0.560
AC:
29910
AN:
53406
Middle Eastern (MID)
AF:
0.677
AC:
3905
AN:
5766
European-Non Finnish (NFE)
AF:
0.643
AC:
714626
AN:
1111870
Other (OTH)
AF:
0.644
AC:
38897
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
21915
43830
65745
87660
109575
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18790
37580
56370
75160
93950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.679
AC:
103276
AN:
152090
Hom.:
36046
Cov.:
32
AF XY:
0.671
AC XY:
49891
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.835
AC:
34653
AN:
41510
American (AMR)
AF:
0.607
AC:
9269
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.721
AC:
2501
AN:
3470
East Asian (EAS)
AF:
0.522
AC:
2696
AN:
5162
South Asian (SAS)
AF:
0.480
AC:
2310
AN:
4808
European-Finnish (FIN)
AF:
0.550
AC:
5820
AN:
10578
Middle Eastern (MID)
AF:
0.680
AC:
200
AN:
294
European-Non Finnish (NFE)
AF:
0.643
AC:
43693
AN:
67970
Other (OTH)
AF:
0.703
AC:
1487
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1600
3199
4799
6398
7998
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
800
1600
2400
3200
4000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.657
Hom.:
168674
Bravo
AF:
0.694
TwinsUK
AF:
0.645
AC:
2393
ALSPAC
AF:
0.655
AC:
2525
ESP6500AA
AF:
0.829
AC:
3652
ESP6500EA
AF:
0.652
AC:
5606
ExAC
AF:
0.619
AC:
75103
Asia WGS
AF:
0.498
AC:
1737
AN:
3478
EpiCase
AF:
0.651
EpiControl
AF:
0.659

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Jun 28, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 03, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 07, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Osteogenesis imperfecta type 6 Benign:3
-
Medical Molecular Genetics Department, National Research Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Osteogenesis imperfecta Benign:1
Jul 18, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
1.2
DANN
Benign
0.92
DEOGEN2
Benign
0.14
T;T;T;T;.
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.012
N
LIST_S2
Benign
0.084
T;T;T;T;T
MetaRNN
Benign
0.0000017
T;T;T;T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
0.97
L;.;.;.;.
PhyloP100
-0.72
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.50
N;.;.;.;.
REVEL
Benign
0.28
Sift
Benign
0.27
T;.;.;.;.
Sift4G
Benign
0.19
T;T;T;T;T
Polyphen
0.0050
B;.;.;.;.
Vest4
0.080
MPC
0.072
ClinPred
0.029
T
GERP RS
-11
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.013
gMVP
0.30
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1136287; hg19: chr17-1673276; COSMIC: COSV54616828; COSMIC: COSV54616828; API